CCL3 genotype and current depression increase risk of HIV-associated dementia

enotype and current depression increase risk of HIV-associated dementia Original Research (4069) Total Article Views Authors: Andrew J Levine, Elyse J Singer, Janet S Sinsheimer, et al Published Date November 2009 Volume 2009:1(Default) Pages 1 - 7 DOI: http://dx.doi.org/10.2147/NBHIV.S6820 Andrew J Levine1, Elyse J Singer1, Janet S Sinsheimer2, Charles H Hinkin3, Jeanette Papp4, Sugandha Dandekar4, Allison Giovanelli5, Paul Shapshak6 1National Neurological AIDS Bank, Department of Neurology, 2Departments of Biomathematics and Human Genetics, 3Department of Psychiatry and Biobehavioral Science, 4Department of Human Genetics, University of California Los Angeles, David Geffen School of Medicine, Los Angeles, CA, USA; 5Department of Psychology, University of California Berkeley, Berkeley, CA, USA; 6Department of Medicine (Division of Infectious Diseases and International Medicine), University of South Florida, College of Medicine, Tampa, FL, USA Background: The prevalence of Human immunodeficiency virus (HIV)-associated dementia (HAD) has continued to rise even as incidence has fallen. Several host genetic variants have been identified that modify risk for HAD. However, the findings have not been replicated consistently and most studies did not consider the multitude of factors that might themselves confer risk for HAD. In the current study, we sought to replicate the findings of previous studies in a neurologically and behaviorally well-characterized cohort. Methods: The sample consisted of 143 HIV+ individuals enrolled in the National NeuroAIDS Tissue Consortium (NNTC). Based on consensus diagnosis, 117 were considered neurologically normal upon study entry, and 26 had HAD. Seven single-nucleotide polymorphisms (SNPs) were genotyped within seven genes (CCL2, CCL3, CCL5, interleukin-1α [IL-1α], IL-10, stromal cell-derived factor 1, and tumor necrosis factor-α). Logistic regression analysis was used to predict group membership (normal vs HAD), with predictor variables including length of infection, age, current drug dependence, current depression, and genotype. Results: The two groups were statistically similar with regards to demographic characteristics, current drug use, and disease factors. The HAD group had significantly greater number of individuals with current depression. Only one SNP, rs1130371 within the gene for CCL3, was entered into the analysis as the others showed symmetric distribution between groups. Logistic regression indicated that current depression and CCL3 genotype were significant predictors of HAD. Depression conferred a fivefold greater risk of HAD, while the TT genotype for CCL3 SNP (rs1130371) was associated with twofold risk for HAD. Conclusion: Depression and CCL3 genotype predicted HAD. The fact that SNPs previously found to be associated with HAD were not in our analysis, and that rs1130371 is in high linkage disequilibrium with neighboring genes indicates that more dense genotyping in significantly larger cohorts is